Organon & Co. Common Stock (OGN) stock analysis

OGN · Organon & Co. Common Stock

Latest recorded price: USD 13.90

Sector and industry: Healthcare · Drug Manufacturers - General

A reliable intrinsic value could not be calculated for OGN; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 0.2%, free cash flow margin 8.7%, ROIC 4.3%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare